Montefiore Health System

remdesivir baricitinib

Montefiore and Einstein College Introduce Trials for Remdesivir-Baricitinib Combo as a Treatment Option for COVID-19

Medicine & Technology May 27, 2020

Montefiore Health System and Albert Einstein College of Medicine have begun with ACTT 2, a clinical trial using the drug combination remdesivir and baricitinib to treat patients with COVID-19. Researchers are hoping the new drug combo would reduce COVID-19-related inflammation and provide better recovery outcomes for coronavirus patients.

Most Popular

How Technology Is Changing the Real Estate Industry?

Study Reveals High Turnover in Scientific Research Careers: What This Means for Future Scientists

Nikolay Karpenko – Founder of Herculis Group

Nikolay Karpenko Biography, Photo, Career, Accomplishments

China’s Tiangong Space Station to Expand Its Capabilities with New Modules

China’s Tiangong Space Station to Expand Its Capabilities With New Modules

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

Recommended Stories

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Power

SPACE

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Energy

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find “Hallucinated” Text in Transcripts

TECH & INNOVATION

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

SPACE

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

NASA Astronaut Hospitalized After Returning from Extended Space Mission

SPACE

NASA Astronaut Hospitalized After Returning from Extended Space Mission